Metraipolis › archive › dc_a5490caba1d9
Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study — Europe PMC PMID:41820335
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41820335
- DOI
- 10.1038/s41467-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T15:14:05.629Z
- SHA-256 of the archived text
2f24ef893d91457609e567ebd59b313da44a6ce6cd46ad15549828942704f8a8- Stable URL of this page
https://metraipolis.com/documento/dc_a5490caba1d9
How to cite
Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study — Europe PMC PMID:41820335 — Europe PMC (en), https://europepmc.org/article/MED/41820335 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5490caba1d9 (Metraipolis archive dc_a5490caba1d9, sha256 2f24ef893d91457609e567ebd59b313da44a6ce6cd46ad15549828942704f8a8)
BibTeX
@misc{dca5490caba1d9,
title = {Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study — Europe PMC PMID:41820335},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41820335},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5490caba1d9; sha256 2f24ef893d91457609e567ebd59b313da44a6ce6cd46ad15549828942704f8a8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41820335. Agents can read the archived copy with the MCP tool read_document.